Gfs Advisors, LLC Novartis Ag Transaction History

Gfs Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $622,017 - $724,218	-7,725 Reduced 73.75%	2,750 $232,000
Q3 2021 Nov 03, 2021	SELL	$81.78 - $95.14 $856,645 - $996,591	-10,475 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$78.07 - $94.43 $817,783 - $989,154	10,475 New	10,475 $989,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $860,416 - $953,225	-10,475 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$84.35 - $95.37 $666,365 - $753,423	-7,900 Reduced 42.99%	10,475 $992,000
Q2 2019 Aug 01, 2019	SELL	$75.4 - $92.8 $6,409 - $7,888	-85 Reduced 0.46%	18,375 $1.68 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $20,712 - $23,691	-275 Reduced 1.47%	18,460 $1.78 Million
Q3 2018 Nov 27, 2018	SELL	$66.94 - $77.43 $346,816 - $401,164	-5,181 Reduced 21.66%	18,735 $1.61 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $72,629 - $84,011	1,085 Added 4.75%	23,916 $2.06 Million
Q2 2018 Aug 08, 2018	BUY	$64.91 - $73.36 $485,851 - $549,099	7,485 Added 48.77%	22,831 $1.73 Million
Q1 2018 May 09, 2018	BUY	$70.39 - $84.15 $200,611 - $239,827	2,850 Added 22.81%	15,346 $1.24 Million
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $41,083 - $44,099	-568 Reduced 4.35%	12,496 $1.05 Million
Q3 2017 Nov 07, 2017	SELL	$74.14 - $77.27 $611,655 - $637,477	-8,250 Reduced 38.71%	13,064 $1.12 Million
Q2 2017 Aug 07, 2017	BUY	N/A	21,314	21,314 $1.78 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfs Advisors, LLC with notifications on news.